Modification by single ubiquitin moieties rather than polyubiquitination is sufficient for proteasomal processing of the p105 NF-kappaB precursor
- PMID: 19250910
- DOI: 10.1016/j.molcel.2009.01.023
Modification by single ubiquitin moieties rather than polyubiquitination is sufficient for proteasomal processing of the p105 NF-kappaB precursor
Abstract
Activation of NF-kappaB is regulated via numerous ubiquitin- and proteasome-mediated steps; an important one is processing of the precursor p105 to the p50 active subunit. The mechanisms involved are largely unknown, because this is an exceptional case where the ubiquitin system does not destroy its substrate completely. Here, we demonstrate that proteasomal processing of p105 requires ubiquitin but not generation of polyubiquitin chains. In vitro, ubiquitin species that cannot polymerize mediate processing. In yeasts that express nonpolymerizable ubiquitins, processing proceeds normally, whereas degradation of substrates that are dependent on polyubiquitination is inhibited. Similar results were obtained in mammalian cells. Interestingly, processing requires multiple monoubiquitinations, because progressive elimination of lysines in p105 is accompanied by gradual inhibition of p50 generation. Finally, the proteasome recognizes the multiply monoubiquitinated p105. These findings suggest that a proteolytic signal can be composed of a cluster of single ubiquitins, not necessarily a chain.
Similar articles
-
Two distinct ubiquitin-dependent mechanisms are involved in NF-kappaB p105 proteolysis.Biochem Biophys Res Commun. 2006 Jun 23;345(1):7-13. doi: 10.1016/j.bbrc.2006.04.036. Epub 2006 Apr 24. Biochem Biophys Res Commun. 2006. PMID: 16678126
-
Modification by single ubiquitin moieties rather than polyubiquitination is sufficient for proteasomal processing of the p105 NF-κB precursor.Adv Exp Med Biol. 2011;691:95-106. doi: 10.1007/978-1-4419-6612-4_10. Adv Exp Med Biol. 2011. PMID: 21153313 No abstract available.
-
Inhibition of p105 processing by NF-kappaB proteins in transiently transfected cells.Oncogene. 1996 Jun 6;12(11):2385-92. Oncogene. 1996. PMID: 8649779
-
[Ubiquitins, proteasomes, sumoylation and therapeutic application today and in future for cancer and other diseases. I. Ubiquitin-proteasome system and the transcription factor NF-kappaB].Vnitr Lek. 2006 Apr;52(4):371-8. Vnitr Lek. 2006. PMID: 16755993 Review. Czech.
-
The role of ubiquitin in NF-kappaB regulatory pathways.Annu Rev Biochem. 2009;78:769-96. doi: 10.1146/annurev.biochem.78.070907.102750. Annu Rev Biochem. 2009. PMID: 19489733 Review.
Cited by
-
Cdc48-independent proteasomal degradation coincides with a reduced need for ubiquitylation.Sci Rep. 2015 Jan 5;5:7615. doi: 10.1038/srep07615. Sci Rep. 2015. PMID: 25556859 Free PMC article.
-
The Role of the Transcription Factor Nuclear Factor-kappa B in Thyroid Autoimmunity and Cancer.Front Endocrinol (Lausanne). 2018 Aug 21;9:471. doi: 10.3389/fendo.2018.00471. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 30186235 Free PMC article. Review.
-
The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges.Pharmacol Ther. 2020 Sep;213:107579. doi: 10.1016/j.pharmthera.2020.107579. Epub 2020 May 19. Pharmacol Ther. 2020. PMID: 32442437 Free PMC article.
-
Targeting proteins for degradation.Nat Chem Biol. 2009 Nov;5(11):815-22. doi: 10.1038/nchembio.250. Nat Chem Biol. 2009. PMID: 19841631 Free PMC article. Review.
-
Degradation of the Saccharomyces cerevisiae mating-type regulator alpha1: genetic dissection of cis-determinants and trans-acting pathways.Genetics. 2010 Jun;185(2):497-511. doi: 10.1534/genetics.110.115907. Epub 2010 Mar 29. Genetics. 2010. PMID: 20351217 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous
